These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8330800)
21. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists. Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats. Yamano M; Ito H; Kamato T; Miyata K Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638 [TBL] [Abstract][Full Text] [Related]
23. The function of 5-HT3 receptors on colonic transit in rats. Haga K; Asano K; Fukuda T; Kobayakawa T Obes Res; 1995 Dec; 3 Suppl 5():801S-810S. PubMed ID: 8653566 [TBL] [Abstract][Full Text] [Related]
24. Effect of 5-HT2 and 5-HT3 receptor antagonists on cholera toxin-induced fluid hypersecretion in the pig jejunum. Grondahi ML; Jensen GM; Skadhauge E; Hansen MB Zentralbl Veterinarmed A; 1996 Nov; 43(9):543-52. PubMed ID: 8968163 [TBL] [Abstract][Full Text] [Related]
25. Liposomes targeted to deliver antisecretory agents to jejunal mucosa. Uwiera RR; Romancyia DA; Wong JP; Forsyth GW Can J Vet Res; 1992 Jul; 56(3):249-55. PubMed ID: 1423062 [TBL] [Abstract][Full Text] [Related]
26. [Effect of Y-25130 on gastric motility in anesthetized rats]. Odani N; Haga K; Setoguchi M Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):17-26. PubMed ID: 8444378 [TBL] [Abstract][Full Text] [Related]
28. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret. Bhandari P; Andrews PL Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456 [TBL] [Abstract][Full Text] [Related]
30. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides. Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602 [TBL] [Abstract][Full Text] [Related]
31. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats. Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524 [TBL] [Abstract][Full Text] [Related]
32. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors. Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198 [TBL] [Abstract][Full Text] [Related]
33. The effects on net fluid transport of noxious stimulation of jejunal mucosa in anaesthetized rats. Timar Peregrin A; Svensson M; Ahlman H; Jodal M; Lundgren O Acta Physiol Scand; 1999 May; 166(1):55-64. PubMed ID: 10372979 [TBL] [Abstract][Full Text] [Related]
34. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats. Szumlinski KK; Frys KA; Kalivas PW Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of cholera toxin-induced intestinal secretion by the 5-HT3 receptor antagonist ICS 205-930. Buchheit KH Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):704-5. PubMed ID: 2770891 [TBL] [Abstract][Full Text] [Related]
36. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Peregrin AT; Ahlman H; Jodal M; Lundgren O Br J Pharmacol; 1999 Jun; 127(4):887-94. PubMed ID: 10433495 [TBL] [Abstract][Full Text] [Related]
37. The role of serotonin in the canine secretory response to cholera toxin in vivo. LaRosa CA; Sherlock D; Kimura K; Pimpl W; Money SR; Jaffe BM J Pharmacol Exp Ther; 1989 Oct; 251(1):71-6. PubMed ID: 2795472 [TBL] [Abstract][Full Text] [Related]
38. Role of mast cells and pro-inflammatory mediators on the intestinal secretion induced by cholera toxin. Rocha MF; Aguiar JE; Sidrim JJ; Costa RB; Feitosa RF; Ribeiro RA; Lima AA Toxicon; 2003 Aug; 42(2):183-9. PubMed ID: 12906889 [TBL] [Abstract][Full Text] [Related]
39. Attenuating effect of serotonin receptor antagonists on impairment of mealtime-associated activity rhythm in old rats. Shibata S; Ono M; Minamoto Y; Watanabe S Pharmacol Biochem Behav; 1995; 51(2-3):541-4. PubMed ID: 7667383 [TBL] [Abstract][Full Text] [Related]
40. Effects of tachykinins and 5-hydroxytryptamine on intestinal secretion. Coupar IM; Di Iulio JL Clin Exp Pharmacol Physiol; 2003 Oct; 30(10):764-8. PubMed ID: 14516416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]